Beyond glucose regulation, asprosin modulates energy metabolism, appetite, insulin secretion, inflammatory responses, apoptotic cell death, and reproductive function, with altered signaling implicated in disorders such as DM, obesity, polycystic ovary syndrome, malignancies, and cardiomyopathies [9–12]. This evidence concerns the gene INS and obesity disorder.